SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-038616
Filing Date
2023-08-04
Accepted
2023-08-04 16:49:09
Documents
12
Period of Report
2023-08-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axsm-20230804.htm   iXBRL 8-K 57024
  Complete submission text file 0000950170-23-038616.txt   170020

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axsm-20230804_lab.xml EX-101.LAB 12806
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axsm-20230804.xsd EX-101.SCH 2451
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axsm-20230804_pre.xml EX-101.PRE 9441
6 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20230804_htm.xml XML 4543
Mailing Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 231144655
SIC: 2834 Pharmaceutical Preparations